TCAM
CVS icon

Turtle Creek Asset Management’s CVS Health CVS Stock Holding History

Turtle Creek Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,500
Closed -$724K – 43
2025
Q2 		$724K Sell
10,500
-1,687,941
-99% -$111M 0.02% 35
2025
Q1 		$115M Sell
1,698,441
-254,550
-13% -$15.2M 3.24% 18
2024
Q4 		$87.7M Sell
1,952,991
-144,676
-7% -$8.12M 2.28% 24
2024
Q3 		$132M Sell
2,097,667
-56,490
-3% -$3.3M 3.17% 18
2024
Q2 		$127M Buy
2,154,157
+436,891
+25% +$27.3M 3.28% 16
2024
Q1 		$137M Buy
1,717,266
+15,666
+0.9% +$1.2M 3.34% 17
2023
Q4 		$134M Sell
1,701,600
-124,950
-7% -$8.89M 3.55% 15
2023
Q3 		$128M Buy
1,826,550
+1,776,200
+3,528% +$126M 3.64% 14
2023
Q2 		$3.48M Buy
50,350
+18,400
+58% +$1.31M 0.1% 27
2023
Q1 		$2.37M Buy
31,950
+26,500
+486% +$2.22M 0.07% 27
2022
Q4 		$508K Buy
5,450
+4,050
+289% +$391K 0.02% 30
2022
Q3 		$134K Buy
+1,400
New +$139K 0.01% 31

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Turtle Creek Asset Management's CVS Position: Q3 2025 in Review

Turtle Creek Asset Management sold out of CVS Health (CVS) in Q3 2025, closing a stake of 10,500 shares — an estimated $724K sold.

Turtle Creek Asset Management first reported a position in CVS in Q3 2022 and held it in 12 quarters. The position peaked at $137M in Q1 2024. 1,837 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

  • Turtle Creek Asset Management reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
  • Turtle Creek Asset Management sold 10,500 CVS Health shares in Q3 2025, an estimated $724K.
  • Turtle Creek Asset Management first reported a position in CVS Health in Q3 2022 and held it in 12 quarters.
  • Turtle Creek Asset Management's CVS Health position peaked at $137M in Q1 2024.
  • 1,837 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Turtle Creek Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.